Compare Krispy Kreme Inc (DNUT) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Krispy Kreme Inc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Krispy Kreme Inc trades at $2.96 (market cap $521.37M), while Iovance Biotherapeutics Inc. Common Stock trades at $14.6 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 11.6× Krispy Kreme Inc's market cap, and Krispy Kreme Inc pays a 3.47% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Krispy Kreme Inc for 46 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| DNUT | IOVA | |
|---|---|---|
Market Cap | $521.37M | $6.04B |
Volume | 2,293,015 | 14,805,993 |
Sector | Consumer Staples | Health |
52-Week High | $4.70 | $14.82 |
52-Week Low | $2.87 | $1.81 |
Typical Hold Time | 46 Days | 0 Days |
Enterprise Value | $1.76B | $5.97B |
Dividend Yield | 3.47% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Krispy Kreme (DNUT) trades at $2.96, up 1.37% today, with a bullish technical signal but mixed fundamentals. Revenue was $1.52B in 2025, but net income was -$516M, reflecting a -33.88% margin. Recent earnings show volatility, with a Q2 2026 beat but a Q1 2026 miss. Analyst consensus is 50% buy, with positive sentiment from new product launches like the Pokémon doughnut collection (Business Wire, 2026-08-13).
Outlook is cautious due to profitability challenges and legal investigations into fiduciary duties (PR Newswire, 2026-09-26). The stock offers value with a low P/S of 0.35, but high debt and negative margins pose risks. Upside depends on cost management and innovation driving sustained earnings growth.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Krispy Kreme Inc
Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates in 30 countries through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S. and Canada, includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line
Read more on DNUT →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
